Komodo Well being and Janssen Analysis & Improvement have signed an settlement to make use of real-world information and synthetic intelligence (AI) software program for accelerating medical improvement.
As a part of the collaboration, feasibility, web site choice, and affected person recruitment will likely be optimised for medical trials.
That is anticipated to drive increased throughput for trials and quick observe life-saving therapies to sufferers.
Komodo Well being chief medical officer Aswin Chandrakantan stated: “The subsequent technology of medical trials requires deep and well timed perception into the affected person journey.
“Whether or not concentrating on a big quantity of numerous sufferers for a prevalent power situation or exploring breakthroughs for advanced uncommon illnesses, it’s essential to know the place sufferers are progressing by means of the care system with a purpose to enhance effectivity in medical trials.”
At current, the partnership focuses on software program options that provide real-time visibility into affected person volumes.
This improves the power to establish trial websites, improve goal recruitment. Moreover, affected person cohorts may very well be understood previous to launch, and attain numerous affected person populations.
The collaboration will cowl therapeutic areas starting from frequent power diseases to ultra-rare illnesses and its areas embrace infectious illnesses, oncology, vaccines, immunology, cardiovascular, and metabolic illness.
The Komodo Well being options are constructed on its Healthcare Map of 325 million US de-identified affected person journeys.
Options which might be being deployed embrace ‘Prism’ to assist affected person cohort analytics, ‘Sentinel’ for information integration, analytics, and web site choice, and ‘Pulse’ for real-time alerts on encounters between suppliers and potential screening eligible sufferers.
Komodo Well being applies AI and different superior information science methods to its Healthcare Map.